Bone Metabolism in Premenopausal Exercising Women
Launched by UNIVERSIDAD POLITECNICA DE MADRID · May 5, 2025
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
To achieve the aim of the study, there will be two experimental groups - e.g. eumenorrhoeic females and oral contraceptive users - who, after screening, will be randomly assigned to a low- or high-energy diet. After 6 days on this diet, the participant will undergo an intervallic running protocol and blood samples will be taken before and after the test. The following month the participant will do the other type of diet.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Be healthy and between 18 and 30 years old.
- • Engage in endurance sports that involve running (such as athletics, running, triathlon, trail running, etc.) for 3 to 12 hours per week..
- • Eumenorrheic females with regular menstruation at least 6 months prior to the study.
- • Monophasic oral contraceptive users at least 6 months prior to the study.
- Exclusion Criteria:
- • Amenorrheic females.
- • Pregnant females.
- • Affected by any disorder related to the hypothalamo-pituitary-ovarian axis.
- • Having suffered a bone fracture in the year before the study.
- • Taking any medication or supplements that affect bone metabolism.
About Universidad Politecnica De Madrid
The Universidad Politécnica de Madrid (UPM) is a leading institution in engineering and technology education, renowned for its commitment to innovation and research excellence. As a clinical trial sponsor, UPM leverages its interdisciplinary expertise to advance medical research and develop novel therapeutic solutions. The university fosters collaborations with healthcare professionals, industry partners, and research organizations to conduct rigorous clinical studies that aim to improve patient outcomes and contribute to the scientific community. With a strong emphasis on ethical practices and regulatory compliance, UPM is dedicated to enhancing the landscape of clinical research through its robust academic framework and cutting-edge facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, Comunity Of Madrid, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported